Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$7.0 - $11.26 $109,200 - $175,656
-15,600 Reduced 72.42%
5,942 $41,000
Q2 2023

Aug 08, 2023

BUY
$7.61 - $9.46 $53,589 - $66,617
7,042 Added 48.57%
21,542 $183,000
Q1 2023

May 12, 2023

BUY
$8.83 - $17.61 $128,035 - $255,345
14,500 New
14,500 $132,000
Q3 2022

Nov 07, 2022

SELL
$16.06 - $26.39 $428,432 - $704,006
-26,677 Reduced 86.84%
4,044 $68,000
Q2 2022

Aug 09, 2022

BUY
$20.49 - $39.72 $456,476 - $884,882
22,278 Added 263.86%
30,721 $659,000
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $238,008 - $393,443
8,443 New
8,443 $312,000
Q4 2021

Feb 11, 2022

SELL
$41.2 - $73.6 $303,602 - $542,358
-7,369 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$59.15 - $91.99 $435,876 - $677,874
7,369 New
7,369 $466,000
Q2 2021

Aug 12, 2021

SELL
$63.02 - $95.11 $352,975 - $532,711
-5,601 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$57.62 - $95.6 $319,848 - $530,675
5,551 Added 11102.0%
5,601 $381,000
Q4 2020

Feb 12, 2021

BUY
$41.43 - $77.09 $2,071 - $3,854
50 New
50 $3,000
Q4 2019

Feb 10, 2020

SELL
$19.24 - $28.41 $13,467 - $19,887
-700 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$20.03 - $40.08 $8,012 - $16,032
400 Added 133.33%
700 $15,000
Q2 2019

Aug 13, 2019

BUY
$25.78 - $39.77 $7,734 - $11,931
300 New
300 $10,000
Q4 2018

Feb 13, 2019

SELL
$19.89 - $30.02 $55,214 - $83,335
-2,776 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$12.1 - $28.85 $4,924 - $11,741
-407 Reduced 12.79%
2,776 $80,000
Q2 2018

Aug 13, 2018

BUY
$7.93 - $15.79 $25,241 - $50,259
3,183 New
3,183 $38,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.